Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1Breast 1

Conditions

Rectal Neoplasms 2Urogenital Neoplasms 1Sarcoma 1Pancreatic Neoplasms 1Neoplasms 1Gastrointestinal Neoplasms 1Fatigue 1Erectile Dysfunction 1Cholangiocarcinoma 1Breast Neoplasms 1

Interventions

pembrolizumab 13Gemcitabine 12Cyclophosphamide 10Carboplatin 10Specimen Handling 8Magnetic Resonance Spectroscopy 8Cisplatin 8Docetaxel 7X-Rays 6Filgrastim 6Doxorubicin 6Biopsy 6tislelizumab 5Radiosurgery 5Phantoms, Imaging 5Paclitaxel 5Nivolumab 5Irinotecan 5Bevacizumab 5130-nm albumin-bound paclitaxel 5spartalizumab 4palbociclib 4Thiotepa 4Temozolomide 4Radiotherapy 4Nuclear Medicine Department, Hospital 4Mesna 4Ipilimumab 4Imatinib Mesylate 4Ifosfamide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma × Sildenafil Citrate × Gastrointestinal × Clear all
NCT01375699 2019-08-26

Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers

Virginia Commonwealth University

Phase 1 Completed
26 enrolled
BreastGastrointestinalSarcoma

Breast Neoplasms, Gastrointestinal Neoplasms, Sarcoma, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡